Learn how the University of Alabama is taking a dogged approach to studying new brain tumor therapies.
We have a lot to gain from accelerating the adoption of NGS testing. The technology exists, but that’s only half the battle. The right approach matters too. Learn more by attending our informative webinar on April 24.
Learn how cardiologists are bringing precision medicine to their patients.
Learn more about All of Us, the landmark study being launched by the NIH, and why we need solutions for streamlining genetic analysis.
Learn more about the predictive phenotyping study being launched by Inova and the NIH.
The drive to deliver precision medicine has galvanized many hospitals to in-source next generation sequencing (NGS) testing. Working with our customers, we’ve established some best practices and will discuss them at the upcoming Executive War College.
Find out how PierianDx customer, HLI, is using genomic data to help understand age-induced disease.
Learn how doctors at Northwestern are taking a precision medicine-based approach to treat patients with rheumatoid arthritis.
The Moffitt Morsani Molecular Laboratory, located within the Moffitt Cancer Center, announced today that it has launched a new clinical NGS assay, Solid Tumor Actionable Result, or STAR. STAR is based […]
Want to learn more about how our technology and services can address the complexity and scale of your genomics? Then visit us at the upcoming ACMG annual meeting in Charlotte, North Carolina.